<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2525">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04649931</url>
  </required_header>
  <id_info>
    <org_study_id>HC-N-H-2006</org_study_id>
    <nct_id>NCT04649931</nct_id>
  </id_info>
  <brief_title>Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease)</brief_title>
  <official_title>Study to Evaluate Whether Differences in Exhaled Breath Can be Identified Using Ion Mobility Spectrometry (IMS) in Subjects Tested Positive for SARS-CoV-2 Infection and Subjects Tested Negative</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>B. Braun Melsungen AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CeGaT GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>B. Braun Melsungen AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Breath gas analysis is the evaluation of exhaled breath. It aims to evaluate the volatile&#xD;
      organic compounds (VOCs) in exhaled breath.&#xD;
&#xD;
      In this feasibility study it is intended to find specific peaks/pattern in exhaled breath&#xD;
      indicating an infection with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 14, 2020</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SARS-CoV-2 related volatile organic compounds (VOC)</measure>
    <time_frame>1 hour after breath gas sampling</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To compare the SARS-CoV-2 specific VOC with the clinical symptoms of COVID-19 (Corona Virus Disease 2019)</measure>
    <time_frame>within 1 hour</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>SARS (Severe Acute Respiratory Syndrome)</condition>
  <condition>Covid19</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ion Mobility Spectrometry (IMS)</intervention_name>
    <description>Two breathing gas samples will be taken from each study participant using ion mobility spectrometry with an ultrasound-based spirometer. The total sampling time is 1 minute (at least 5-7 breath takes) following an analysis time of 5-12 minutes.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with suspected or diagnosed SARS-CoV-2 infection.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  PCR (= Polymerase Chain Reaction) testing for SARS CoV-2 will be/has been performed in&#xD;
             a timely manner of sampling exhaled breath or PCR test for SARS-CoV-2 was performed&#xD;
             within 96 hours, but preferably within 48 hours before sampling exhaled breath and PCR&#xD;
             test result is already available&#xD;
&#xD;
          -  Subject must be able to comply with study-specific procedures, e.g.is able to comply&#xD;
             with breathing commands&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous (history) SARS-CoV-2 infection, independent of the current episode&#xD;
&#xD;
          -  Participation in a therapeutic study prior to breath analysis which could influence&#xD;
             the result of the breath analysis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juergen Schaefer, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Marburg, Zentrum für unerkannte und seltene Erkrankungen (ZusE)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Study Manager</last_name>
    <phone>00495661</phone>
    <phone_ext>710</phone_ext>
    <email>studies@bbraun.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Gießen and Marburg (UKGM), site Marburg</name>
      <address>
        <city>Marburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juergen Schaefer, Prof. Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Juergen Schaefer, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 25, 2020</study_first_submitted>
  <study_first_submitted_qc>November 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2020</study_first_posted>
  <last_update_submitted>December 15, 2020</last_update_submitted>
  <last_update_submitted_qc>December 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

